-
Mashup Score: 1Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms - 12 day(s) ago
A video from Ayalew Tefferi (as part of Indy Hematology Review), posted on Apr 24, 2024.
Source: www.vumedi.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 1Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas. | Read by QxMD - 3 month(s) ago
Despite recent advances in frontline therapy for diffuse large B-cell lymphoma (DLBCL), at least a third of those diagnosed still will require second or further lines for relapsed or refractory (rel/ref) disease. A small minority of these can be cured with standard chemoimmunotherapy/stem-cell transplant salvage approaches. CD19-directed chimeric antigen receptor T-cell (CAR-19) therapies are increasingly altering the prognostic landscape for rel/ref patients with DLBCL and related aggressive B-cell
Source: read.qxmd.comCategories: General Medicine News, Hem/OncsTweet-
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas. https://t.co/z9dDrDv3Gs #lymsm #DLBCL
-
-
Mashup Score: 1
Program: Oral and Poster Abstracts Type: Oral Session: 627. Aggressive Lymphomas: Clinical and Epidemiological: Treatment to Best Outcomes: Find the Right Therapy for the Right Patient Hematology Disease Topics & Pathways: Research, non-Hodgkin lymphoma, Lymphomas, Combination therapy, Clinical Research, B Cell lymphoma, Diseases, Therapies, real-world evidence, aggressive lymphoma, Lymphoid Malignancies 1 Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study https://t.co/BIHowOrS72
-
-
Mashup Score: 17
Program: Oral and Poster Abstracts Type: Oral Session: 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Novel Therapies For Relapsed/Refractory Aggressive Lymphoma Hematology Disease Topics & Pathways: Research, clinical trials, Biological therapies, adult, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Clinical Research, B Cell lymphoma, Diseases, aggressive lymphoma, Therapies, Lymphoid Malignancies, Biological Processes, molecular biology, Study Population, Human, Transplantation
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Primary Analysis Phase III https://t.co/DBYAuIpMLd
-
-
Mashup Score: 1
Program: Oral and Poster Abstracts Type: Oral Session: 627. Aggressive Lymphomas: Clinical and Epidemiological: Treatment to Best Outcomes: Find the Right Therapy for the Right Patient Hematology Disease Topics & Pathways: Research, non-Hodgkin lymphoma, Lymphomas, Combination therapy, Clinical Research, B Cell lymphoma, Diseases, Therapies, real-world evidence, aggressive lymphoma, Lymphoid Malignancies 1 Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study https://t.co/BIHowOrS72
-
-
Mashup Score: 262024 Update: Advances in the risk stratification and management of large B‐cell lymphoma - 6 month(s) ago
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
American Journal of Hematology | Blood Research Journal | Wiley Online Library https://t.co/ufj2YthOZW #lymsm #DLBCL #esolymphomaCCL6
-
-
Mashup Score: 1
Program: Oral and Poster Abstracts Type: Oral Session: 627. Aggressive Lymphomas: Clinical and Epidemiological: Treatment to Best Outcomes: Find the Right Therapy for the Right Patient Hematology Disease Topics & Pathways: Research, non-Hodgkin lymphoma, Lymphomas, Combination therapy, Clinical Research, B Cell lymphoma, Diseases, Therapies, real-world evidence, aggressive lymphoma, Lymphoid Malignancies 1 Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study https://t.co/BIHowOrS72
-
-
Mashup Score: 17
Program: Oral and Poster Abstracts Type: Oral Session: 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Novel Therapies For Relapsed/Refractory Aggressive Lymphoma Hematology Disease Topics & Pathways: Research, clinical trials, Biological therapies, adult, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Clinical Research, B Cell lymphoma, Diseases, aggressive lymphoma, Therapies, Lymphoid Malignancies, Biological Processes, molecular biology, Study Population, Human, Transplantation
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Primary Analysis Phase III https://t.co/DBYAuIpMLd
-
-
Mashup Score: 0Paper: Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on? - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: adult, Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Diseases, aggressive lymphoma, real-world evidence, Lymphoid Malignancies, Human, Study Population Magdalena Klanova 1,2 *, Samuel Hricko, MD 3 *, Michal Masar, MD 4 *, David Salek, MD 3 *, Prokop Vodicka 5 *, Natasa Kopalova 3 *, Petra Blahovcova 5 *, Katerina Benesova, MD, CSc 4 *, Jozef Michalka, MD
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Paper: Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on? https://t.co/szYGIgNYXq
-
-
Mashup Score: 0Médicos Sem Fronteiras - 7 month(s) ago
Seja qual for a forma, sua ajuda é mais do que necessária. Colabore! É graças a essas contribuições constantes que nossas equipes estão sempre prontas para agir e levar atendimento médico a quem precisa, mesmo nos lugares mais remotos ou nos contextos mais difíceis. **Nosso trabalho é salvar vidas todos os dias e é por isso que contar com a sua ajuda é muito importante para nós!** Você pode escolher a de sua preferência e nos ajudar a salvar vidas! DOAÇÕES São as doações constantes de pessoas como você
Source: doe.msf.org.brCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @sylviadalcolmo: Em tempos tão sombrios, algo para se sentir menos imponente: Médicos Sem Fronteiras https://t.co/fy4c8f6dcN
-
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms #Tefferi https://t.co/MZ2EiHi3XU via @vumedi